glp 1 drug market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Market Size, Share |

Cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) remain first-line evidence-based treatments for BED, with robust data supporting their efficacy

This study explores real-world outcomes of oral semaglutide (GLP-1 receptor agonist) in Indian patients with Type 2 Diabetes Mellitusan area where data remain limited in India

Consistent with these effects, GLP-1 RAs have been associated with substantial weight loss in clinical trials, leading to FDA approval of two of these agents liraglutide and semaglutide for chronic weight management in adults with obesity or with overweight and at least one weight-related comorbidity

In 2022, the trulicity segment is influencing the market with the largest market share during the forecast period

Animal models show intestinal protection from GLP-1 receptor agonists

These check-ins include reviewing weight loss progress, tracking any side effects, and addressing any concerns that may arise